Last updated on June 2016

Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS

Brief description of study

The objective of this study is to assess the immunogenicity and safety of the DTaP-IPV combination vaccine compared with those of separate DTaP and IPV vaccines administered to healthy infants at 2, 4, and 6 months of age.

Detailed Study Description

A multicenter, randomized, comparative, open-label, phase 3 study Primary Objective: To assess the vaccine response rates after the three-dose primary vaccination Secondary Objectives: To measure the antibody titer after the three-dose primary vaccination and to assess the safety of the investigational products

Clinical Study Identifier: NCT02458183

Contact Investigators or Research Sites near you

Start Over

JD Kim

Wonkwang University Hospital
Jeonbuk, Korea, Republic of
  Connect »